Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
4 cycles of FEC followed by 4 cycles of Nab-paclitaxel FEC:Epi 100mg/m2 and CPA 500mg/m2 and 5-FU 500mg/m2,day1 every 3weeks Nab-paclitaxel:260mg/m2,day1 every 3weeks
2 trials
Sponsors
Graduate school of medicine,Chiba University
Conditions
breast cancer
Unknown Phase
Feasibility study of adjuvant nab-paclitaxel in breast cancer
Recruiting
JPRN-UMIN000007725
Graduate school of medicine,Chiba University
breast cancer
Start: 2012-02-01
Target: 55
Updated: 2026-06-29
Primary systemic therapy of nab-paclitaxel in breast cancer patients
Recruiting
JPRN-UMIN000007724
Graduate school of medicine,Chiba University
breast cancer
Start: 2012-02-01
Target: 36
Updated: 2026-06-29
Related Papers
Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).
2021-04-03
8 citations